ScripSan Francisco start-up 3T Biosciences came out of stealth mode on 25 August with $40m in new venture capital from a series A round led by Westlake Village BioPartners with participation from Lightsp
ScripVenture capital firms focused on biopharmaceutical companies raised $810m across two new funds during the past two weeks, including $550m for venBio and Ysios Capital’s recently closed €216m ($260m) f